Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Inflammation damages myelin and oligodendrocytes
The peptide backbone is modeled after the native GIP sequence, heavily modified with specific amino acid substitutions and conjugated to a C20 fatty diacid side chain via a hydrophilic spacer
Product is not available in Arkansas, Indiana, Minnesota, Puerto Rico, or South Carolina
Initially, treatment response should be assessed every 3 months according to the clinical expert although this is dependent on patient factors such as drug tolerance
General disorders and administration site conditions The SOC of general disorders and administration site conditions encompassed 31 PTs from the FAERS database, predominantly related to administration site events
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets
